Shai-Hulud Malware Source Code Leak Fuels Major npm Supply Chain Attack: Technical Analysis, Impact, and Mitigation Strategies Rescana
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
